Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Microbial Control Biological Technology Co., Ltd. (HBWK) is a high-tech enterprise specializing in the research, development, and large-scale manufacture of fine chemicals for microbial control and disinfection. The company is notably the first in China to implement a continuous production process for glutaraldehyde (glutaric dialdehyde), establishing itself as a leading global supplier of medicinal-grade disinfectants and industrial biocides. Its products are widely utilized in medical sterilization, industrial water treatment, and as intermediates in organic synthesis and protein research. HBWK operates a significant manufacturing facility in Hubei, China, and maintains an international presence, exporting to markets in the EU, United States, and Russia. The company is recognized for its independent core technologies and adherence to international quality and environmental management standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Microbial Control Biological Technology.